Roche Holding AG Akt 0.44% CHF240.7B ...

Dyne Therapeutics Inc.-0.29% $1.38B ...

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $48.00. The company’s shares closed ...

After hours: February 25 at 6:55:12 PM EST Loading Chart for CATX ...

Summit Therapeutics (SMMT) announced a clinical trial collaboration with Pfizer (PFE) to evaluate ivonescimab, an investigational PD-1 / VEGF bispecific antibody, in combination with several of ...

After hours: February 26 at 5:12:38 PM EST Loading Chart for NRIX ...

While the UN Global Compact logo is for use by our initiative only, we encourage participants in good standing to use the Endorser "We Support" logo. It can be used, for example, on websites and ...

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...